PedAM
Pediatric Disease Annotations & Medicines
| Disease | sleep apnea |
| Symptom | |hypertension |
| Sentences | 56 |
| PubMedID- 20875159 | Furthermore, several studies suggest amelioration of hypertension with therapy for sleep apnea. |
| PubMedID- 22145130 | A rise in sympathetic activity is also noted in patients with hypertension associated with obstructive sleep apnea, obesity, chronic kidney disease, prediabetes, and heart failure. |
| PubMedID- 21844482 | We evaluated the effects of this procedure on bp and sleep apnea severity in patients with resistant hypertension and sleep apnea. |
| PubMedID- 24574958 | Thus, the effects of both peripheral and central chemoreceptors may contribute to promoting hypertension in patients with obstructive sleep apnea who undergo repeated bouts of asphyxia nightly (cooper et al., 2005). |
| PubMedID- 26291659 | Animal models of chronic intermittent hypoxia (cih) mimic the hypertension observed in patients with obstructive sleep apnoea. |
| PubMedID- 24622919 | Background: obstructive sleep apnea (osa) is associated with hypertension and the progression of chronic kidney disease (ckd). |
| PubMedID- 25203003 | Bidirectional relationship of hypertension with obstructive sleep apnea. |
| PubMedID- 26251511 | Sympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxia. |
| PubMedID- 23340085 | Objectives: pilot studies have described the occurrence of sleep apnea in patients with precapillary pulmonary hypertension (ph). |
| PubMedID- 25456788 | Intracranial hypertension associated with obstructive sleep apnea: a discussion of potential etiologic factors. |
| PubMedID- 23369399 | Background: idiopathic intracranial hypertension may be associated with sleep apnea. |
| PubMedID- 25121756 | Objective(s): twenty-four-hour ambulatory blood pressure monitoring (abpm) seems to be the most accurate way of diagnosing hypertension in patients with obstructive sleep apnea (osa). |
| PubMedID- 25264755 | Repetitive hypoxia is involved in the pathogenesis of coronary artery disease, myocardial infarction, hypertension, and stroke in patients with obstructive sleep apnea.34–36 it is tempting to suggest that exaggerated vasoconstrictions due to increased cimp formation by sgc during the sleep apnea episodes contribute to the development of these cardiovascular disorders. |
| PubMedID- 21881475 | Obstructive sleep apnea (osa) is associated with hypertension (htn) and cardiovascular disease. |
| PubMedID- 24371473 | In selected patients (type 2 diabetes mellitus, sleep apnea syndrome with resistant hypertension, sudden deterioration in hypertension control), prevalence could be higher. |
| PubMedID- 25084263 | The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. |
| PubMedID- 23163313 | The model also captured costs associated with medication for diabetes, asthma, hypertension, and hyperlipidemia, costs of diabetes complications, sleep apnea, and asthma, and costs of diagnostic tests. |
| PubMedID- 26557386 | Another important topic covered is the implications of renal denervation, a rather novel and increasingly studied potential therapy for hypertension, in patients with sleep apnea. |
| PubMedID- 20592572 | Background: obstructive sleep apnea (osa) is associated with hypertension, atrial fibrillation, coronary artery disease, congestive heart failure, and diabetes. |
| PubMedID- 24879492 | Objective: the high prevalence of obstructive sleep apnea in patients with resistant hypertension could be mediated by an activation of the renin-angiotensin-aldosterone system. |
| PubMedID- 22760852 | Nocturnal awakenings accompanied by intense headache crises in individuals with obstructive sleep apnea have been associated with intracranial hypertension (89). |
| PubMedID- 20804865 | Thus, persistent sympathetic activation and hypertension associated with sleep apneas seems to be due to a combination of altered chemo- and baro-reflexes resulting in sympathetic activation and action of elevated circulating levels of vasoactive hormones on vasculature. |
| PubMedID- 24142787 | hypertension in the course of obstructive sleep apnoea is often resistant to therapy despite the use of continuous positive airway pressure devices, and often decrease after the use of aldosterone antagonists. |
| PubMedID- 22407199 | Obstructive sleep apnea (osa) is associated with diabetes, hypertension, stroke, coronary artery disease, and premature death. |
| PubMedID- 23852938 | Objectives/hypothesis: sleep apnea is associated with hypertension and diabetes, putting these patients at high risk for developing cardiovascular disease. |
| PubMedID- 20144073 | The results of this study indicated that the bp in the sleep apnea patients with hypertension might gradually decrease by revised uppp surgery. |
| PubMedID- 24944841 | Like excess weight, sleep disorders, particularly sleep apneas, have been associated with hypertension , coronary artery disease , heart failure , and diabetes 9. |
| PubMedID- 20560730 | Comparison of the effects of nebivolol and valsartan on bp reduction and sleep apnoea activity in patients with essential hypertension and osa. |
| PubMedID- 25429271 | Autonomic dysfunction is involved in the development of hypertension in humans with obstructive sleep apnea, and animals exposed to chronic intermittent hypoxia (cih). |
| PubMedID- 25680417 | Continuous positive airways pressure and uvulopalatopharyngoplasty improves pulmonary hypertension in patients with obstructive sleep apnoea. |
| PubMedID- 26102761 | 2b.03: uric acid levels related to obstructive sleep apnea syndrome in patients with hypertension from xinjiang of china. |
| PubMedID- 22388231 | Although resistant hypertension was associated with severe sleep apnea in participants with esrd odds ratio (or) 7.1, 95% confidence interval (ci) 2.2-23.2), there was no significant association in the non-ckd (or 3.5, 95% ci 0.8-15.4) or ckd groups (or 1.2, 95% ci 0.4-3.7) after accounting for case-mix. |
| PubMedID- 20185739 | sleep apnea is associated with diabetes, hypertension, and cardiovascular disease. |
| PubMedID- 22474497 | Excluded were women who had practiced yoga within the last year, had uncontrolled hypertension, had been diagnosed with sleep apnea or with diabetes, cancer, heart failure, or other serious chronic disorders, or had any orthopedic, neurological, or other condition that might prevent them from safely completing an 8-week yoga program. |
| PubMedID- 20122554 | Background and purpose: ambulatory blood pressure monitoring (abpm) provides an accurate assessment of blood pressure (bp) and shows non-dipper bp pattern in many sleep apnea syndrome (sas) patients with hypertension (htn); however, little information is available on the relationship between the severity of sas and circadian bp changes in sas patients without htn. |
| PubMedID- 20154650 | The burden of obstructive sleep apnea along with masked hypertension on elastic properties. |
| PubMedID- 22745646 | However, we could not find any reports of pulmonary hypertension due to sleep apnea in children with rts. |
| PubMedID- 24918372 | Background: obstructive sleep apnea is associated with hypertension, inflammation, and increased cardiovascular risk. |
| PubMedID- 24548330 | hypertension was a predictor of having obstructive sleep apnoea (or = 2.78, 95% ci 1.15-6.75, p = 0.02), while haemoglobin >/= 15 g/dl was associated with central sleep apnoea (or = 6.71, 95% ci 1.96-22.99, p = 0.002). |
| PubMedID- 24877123 | performed an elegant study evaluating the effect of hypoxia (a component of obstructive sleep apnoea, closely associated with hypertension) on the renal proteome in sprague-dawley rats. |
| PubMedID- 22655109 | The association between sleep related breathing disorders and cardiovascular disease is further stressed by reports of a high prevalence of sleep apnoea among patients with hypertension 3. |
| PubMedID- 23869411 | The pathogenesis of hypertension in patients with obstructive sleep apnea (osa) is associated with endothelial dysfunction induced by chronic intermittent hypoxia (ih). |
| PubMedID- 23937437 | In contrast, hifs contribute to the pathogenesis of pulmonary arterial hypertension, systemic hypertension associated with sleep apnea, ocular neovascularization, hereditary erythrocytosis, and cancer. |
| PubMedID- 23509623 | Therapeutic strategies for sleep apnea in hypertension and heart failure. |
| PubMedID- 26211157 | Objective: to analyze the differences of sleep respiratory parameters recorded by psg and synchronous blood pressure measured by ambulatory blood pressure monitor between obstructive sleep apnea (osa) patients with hypertension (ht) and simple osa and simple ht; to determine the characteristics of sleep respiratory parameters and blood pressure changes in patient with osa accompanied ht. |
| PubMedID- 26252911 | Age, body mass index, and daytime and nocturnal hypoxia as predictors of hypertension in patients with obstructive sleep apnea. |
| PubMedID- 25102963 | Systemic hypertension is associated with obstructive sleep apnoea syndrome (osas) but the pathophysiological mechanisms are incompletely understood. |
| PubMedID- 23956553 | Obstructive sleep apnea (osa) is associated with hypertension, metabolic syndrome, diabetes, heart failure, coronary artery disease, arrhythmias, stroke, pulmonary hypertension, and neurocognitive and mood disorders. |
| PubMedID- 23288434 | Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. |
| PubMedID- 21106625 | Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. |
Page: 1 2